About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Friday, March 27th, 2015

The QualityStocks
Daily Stock List


Cirque Energy, Inc. (EWRL)

PennyStocks24, Information Solutions Group, and USA Market News reported previously on Cirque Energy, Inc. (EWRL), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Cirque Energy, Inc. focuses on the generation and delivery of clean energy and energy efficient solutions. This includes Combined Heat and Power (CHP) projects, industrial cogeneration, waste-to-energy, biomass, natural gas, and building energy efficiency improvements. It has developed a strategic plan to create sustainable, renewable energy with waste-to-energy power plants and the production of waste derived fuels. An energy services company (ESCO), Cirque Energy is headquartered in Detroit, Michigan.

The Company operates with long-term supply agreements to process waste materials into valuable recyclables and reduce waste volume going into landfills by up to 85 percent. Cirque Energy provides its services to a diverse client base. This includes industrial and commercial customers; municipalities, universities, schools, and hospitals (MUSH); and federal, state and local clients.

The Company, as an ESCO, normally provides its services so that the new infrastructure is developed and owned by Cirque Energy. Project energy is then sold to a customer using different structures, which require little or no capital outlay by the customer.

Cirque is working in partnership with Northrop Grumman Corp. to bring to market a deployable gasification unit (DGU), which can use solid waste to supplement traditional fuels used to generate CHP. The Company has proprietary gasification technology designed for CHP applications that can use waste fuels to produce low cost, renewable energy in the 200-2,500 kW market.

The DGUs use Cirque's gasification and syngas condition technology, combined with conventional reciprocating engine generator technology.  Any carbon-based waste stream of roughly 2-10 tons daily can be cleanly and efficiently turned into CHP energy. CHP is an efficient and clean approach to producing electric power and useful thermal energy from a single fuel source.

Cirque Energy will evaluate a facility’s potential for implementation of a CHP project, for little or no upfront costs. The review can also include an evaluation of existing facility energy use to establish if energy efficiency measures can be put into operation to help offset overall energy requirements.

Earlier this month, Cirque Energy announced updates to its business strategy. It is working to bring its technology and products to market faster, generate revenue sooner, and build shareholder value. The three main components of its market strategy include commercialization of the Deployment Gasification Unit (DGU) technology; development and delivery of Combined Heat and Power (CHP) projects as an Energy Services Company (ESCO); and strategic acquisitions of existing biomass power plant facilities with historical operating income and continuing revenue generation, post-acquisition.

Cirque Energy, Inc. (EWRL), closed Friday's trading session at $0.0083, up 5.06%, on 2,950,414 volume with 55 trades. The average volume for the last 60 days is 1,346,357 and the stock's 52-week low/high is $0.007/$0.0299.

BioCorRx, Inc. (BICX)

SizzlingStockPicks, Stock Shock and Awe, Penny Stock General, Fast Money Alerts, PennyStocks24, Winston Small Cap, Shiznit Stocks, Impressive Penny Stocks, Pennystocktweeters.com, Fabulous Penny Stocks, BUYINS.NET, SmallCapVoice, Center Stage Stocks, and Market Wire Stocks reported on BioCorRx, Inc. (BICX), and we are reporting on the Company as well, here at the QualityStocks Daily Newsletter.

BioCorRx, Inc. is a leader in addiction treatment and rehabilitation programs. It has developed a highly effective program called the Start Fresh Program™ consisting of two components used by different addiction clinics in the United States. Clinic reports show that the Start Fresh Program™ has an 85 percent success rate with individuals that complete the program.

The Company’s vision is to work to make the Start Fresh Program™ the preeminent, long-term alcohol recovery program used by treatment centers around the world for alcoholics, and their family and friends. BioCorRx announced, in 2014, the expansion of its Start Fresh Program™. The Company is opening up the program to treat opioid addiction, because of an increasing problem to society, as well as patient demand.

The first component of the Start Fresh Program™ consists of an outpatient implant procedure performed by a licensed physician, which delivers therapeutic levels of the drug Naltrexone into the body. Naltrexone is an opioid antagonist that significantly reduces physical cravings for alcohol and opioids.

The second component of the program developed by BioCorRx is a one-on-one coaching program. This program is specifically tailored for the treatment of alcoholism and other substance abuse addictions.

BioCorRx secured license agreements last year for 10 additional states and direct distribution deals with clinics in two other states owned by Dr. George Fallieras (medical director of Start Fresh Recovery). Currently, a number of clinics are open, serving patients using the Start Fresh Program™.

Recently, BioCorRx announced expansion into Texas with the opening of a Start Fresh Recovery clinic in the Dallas metropolitan area. The new center will be opened due to an agreement with Start Fresh Management, LLC. Start Fresh Management currently manages many Start Fresh Recovery centers across the nation. The center is located at 4104 W 15th Street, Suite 202, Plano, Texas 75093.

This week, BioCorRx announced the execution of a definitive agreement with Myriad Medical Marketing (MMM). BioCorRx had earlier announced the Letter of Intent (LOI) to enter into an agreement with MMM on February 27, 2015. With the agreement, MMM will become the exclusive sales agent for BioCorRx within the Wellness Center category across the U.S. with the exception of licensee owned territories. In addition, BioCorRx recently announced a supply and distribution agreement with the first wellness center in Corona, California for a pilot program. Four other wellness centers are planned to be a part of the pilot program.

BioCorRx, Inc. (BICX), closed Friday's trading session at $0.10, up 17.65%, on 716,678 volume with 117 trades. The average volume for the last 60 days is 115,954 and the stock's 52-week low/high is $0.04/$0.1975.

Vertical Computer Systems, Inc. (VCSY)

TopPennyStockMovers, Stockpalooza, StockHotTips, and Stockwatch 411 reported earlier on Vertical Computer Systems, Inc. (VCSY), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed Vertical Computer Systems, Inc. is an international provider of complementary and integrated application software, cloud-based and software services, Internet core technologies, and intellectual property (IP) assets via its distribution network with operations or sales in the United States, Canada, and Brazil. Its primary administrative software product is emPath®. Vertical Computer Systems has its corporate headquarters in Richardson, Texas.

The Company’s business model combines complementary, integrated software products, internet core technologies, and a multinational distribution system of partners. This is to create a distribution matrix that it believes can penetrate many sectors by way of cross promotion.

Vertical Computer Systems’ main Internet core technologies include SiteFlash™, and the Emily XML™ Scripting Language, which can be utilized to build web services. The Company’s SiteFlash™ technology employs XML and publishes on the web. This enables the user to build and efficiently operate websites with the distinct ability to separate form, function, and content.

The design of its emPath® is to handle complex Payroll and Human Resources challenges. It is a fully web-based HRMS solution. emPath® provides full administrative and workflow capabilities, and employee empowerment through employee and manager self-service. emPath® is developed, marketed, as well as maintained by NOW Solutions, Inc.

Vertical Computer Systems’ primary emphasis is to leverage the strength of its products including SiteFlash™, and emPath®, to its existing network of customers and vendors. Additionally, the Company works to enter into co-marketing agreements with other companies whose products are proven and best of breed; profitable or on the path to profitability; complement each other, and provide cross-product distribution channels.

The Company’s Emily™ technology provides innovative software for e-commerce, information technologies, web-based data management, and process control. The central component of the Emily™ technology is the powerful MLE Markup Language Executive. This is a patent pending, extensible, multi-platform scripting language with built-in parsing of XML and HTML data. This includes support for SQL databases.

In addition, Vertical Computer Systems offers its ResponseFlash™. This is a high-end software package. ResponseFlash™ provides a secure, integrated, comprehensive solution for government agencies that have a need to provide fast response systems to other agencies and departments.

Vertical Computer Systems, Inc. (VCSY), closed Friday's trading session at $0.05, up 21.95%, on 2,642,643 volume with 107 trades. The average volume for the last 60 days is 458,793 and the stock's 52-week low/high is $0.0095/$0.075.

Acology, Inc. (ACOL)

SmallCapVoice, Greenbackers, PennyStockRumors.net, Actual Gains, PricelessPennyStocks, OTPicks, Orbit Stocks, Equity Observer, and Jet-Life Penny Stocks reported this week on Acology, Inc. (ACOL), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Acology, Inc. is a bottle design, manufacturing, branding and sales company. It is bringing to the forefront the first-ever polypropylene (PP) airtight, watertight, smell-proof delivery and storage system with a built-in grinding component. This is the MedTainer™, which the Company markets and sells. Target markets for the MedTainer™ include Private and Compounding Pharmacies, Oriental and Traditional Herbal Pharmacists, and Veterinary Clinicians. Acology is headquartered in Corona, California.
Acology markets the MedTainer™ via distributors in the United States and Canada and over its website, www.themedtainer.com.  The 4th and 5th generation MedTainer is patented and Food and Drug Administration (FDA) approved. The MedTainer™ is manufactured from medical-grade No. 5 polypropylene resin. This is non-porous and non-leaching. These containers are portable.

The MedTainer™ is child resistant and it features a built-in grinder that grinds pills, herbal medications, coffee beans, and teas into fine powder. The container's grinding teeth have been reinforced for greater wear and simpler manipulation.

The Rein Group, Inc. conducted tests, and it was established that pills large and small were easily made into powder form in under 30 seconds. Enteric-coated pills and pills that are not easily crushed or cut in half were also easily reduced to powder in under 30 seconds.

With Acology containers, consumers can easily store, carry, and consume herbal remedies, pharmaceuticals, teas, and any other solid or liquid content. Acology adheres closely to the rigid compliance standards of the medical industry. As a result, it can provide the medical professional with the ability to store, mix, and distribute medications in solid form without the fear of cross-contamination.

Acology is also in the process of bringing all of its printing in-house. This will decrease turn-around time for custom orders.

Last month, Mr. Curtis Fairbrother, Chief Executive Officer, said," We are having our best sales month since company inception, and bringing our printing in-house will not only makes us more efficient but it will also increase our bottom line. We are working hard on bringing additional products to market as well."

Acology, Inc. (ACOL), closed Friday's trading session at $0.0051, up 6.25%, on 4,031,726 volume with 49 trades. The average volume for the last 60 days is 1,786,632 and the stock's 52-week low/high is $0.002/$1.25.

UMED Holdings, Inc. (UMED)

We are reporting on UMED Holdings, Inc. (UMED), here at the QualityStocks Daily Newsletter.

UMED Holdings, Inc. is a diversified holding company that lists on the OTC Markets Group’s OTCQB. It owns and operates businesses in an assortment of industries. These include energy, oil and gas, aerospace, food and beverage, and mining. The Company’s focus is to acquire businesses as wholly-owned subsidiaries that have stable, solid management; the immediate ability to grow exponentially with steady growth to follow, and an emphasis on emerging markets. UMED Holdings is headquartered in Fort Worth, Texas.

UMED’s portfolio includes Greenway Innovative Energy, Inc. (Natural Gas-To-Liquid technology), Mamaki of Hawaii, Inc. (Mamaki tea plantation in Hawaii), Logistix Technology Systems, Inc. (technology and asset management tool for the Oil and Gas Industry), Jet Tech (aviation maintenance services company), and Arizona One, LLC (1,440 acres of Bureau of Land Management (BLM) land in Arizona).

UMED’s Greenway Innovative Energy, Inc. (GIE) wholly-owned subsidiary (a provider of proprietary, mobile Gas-to-Liquids (GTL) technology) entered into a Sponsored Research Agreement (SRA) in May 2014 with the University of Texas at Arlington to further refine and enhance its leading-edge technology that converts natural gas to clean synthetic fuels. The purpose of the Research Agreement with the University is to continually improve the existing Fisher-Tropsch synthesis process for the conversion of natural gas into liquid hydrocarbons, or synthetic fuels.

UMED Holdings announced in 2013 that it agreed to acquire the remaining 50 percent interest in Rig Support Services, Inc. (RSSI) (nka Logistix Technology Systems, Inc.). RSSI is a privately held Texas Corporation focused on developing a unique and valuable technology and asset management Tool for the Oil and Gas Industry.

The design of this tool is to provide independent rig owners and operating companies the ability to more accurately view and report on drilling operations and allow for a more streamlined approach to processing purchase orders, receiving parts, saving dollars to ensure increased efficiency by substantially decreasing rig down-time because of mechanical break-downs.

UMED Holdings also announced in 2013 that it exercised its option under the terms of a pre-existing acquisition agreement to acquire the remaining 20 percent interest of Mamaki of Hawaii (MOH). MOH focuses on growing, harvesting, processing and marketing Mamaki herbal tea and extract. MOH has the only commercially approved and certified Mamaki tea farm in the world (26 acres). MOH is the owner and operator of Wood Valley Plantation, situated in the Kau district of the Big Island.

This past October, UMED Holdings, through its wholly-owned subsidiary Greenway Innovative Energy, announced the issuance by the US Patent Office of an additional patent, which covers the Company’s mobile Gas-to-Liquids (GTL) conversion unit for converting natural gas to clean synthetic fuels. US patent number 8,795,597 covers claims associated with the process of transforming natural gas into hydrocarbon in a portable and mobile conversion unit. The process involves removing sulfur from the natural gas and converting it into synthetic gas.

UMED Holdings, Inc. (UMED), closed Friday's trading session at $0.15, up 15.38%, on 103,2466 volume with 7 trades. The average volume for the last 60 days is 20,637 and the stock's 52-week low/high is $0.105/$0.35.

Net Talk.com, Inc. (NTLK)

Epic Stock Picks, EpicVIP Group, TheMicrocapNews, Greenbackers, and Nebula Stocks reported on Net Talk.com, Inc. (NTLK), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Net Talk.com, Inc. (netTALK) is a leading ultra-low cost provider of home phone and smartphone communications. The Company was founded in 2008 by Anastasios “Takis” Kyriakides. His idea was to take advantage of the ongoing technology revolution to give consumers freedom of choice and to free them from outdated, expensive, legacy systems. NetTALK is based in Miami Gardens, Florida.

netTALK’s flagship product is the netTALK DUO. It enables anyone to Fire Your Phone Company® and never pay a monthly phone bill again. The netTALK DUO and the netTALK smartphone app are freeing consumers and small business owners from monthly phone bills and cellular talk minutes.

Recently, netTALK and SHEnetics announced a strategic partnership to jointly launch next generation intelligent phone services to netTALK's residential subscribers. The focus of these unique services are on voice powered personal assistant capabilities for enhanced voicemail, voice dialing, home control, calendaring, alerts, reminders and web search.

SHEnetics is a pioneer in AI based personal digital assistant technology. SHE Simulated Human Experience® is a technology platform for original equipment manufacturers (OEM's) and 3rd party developers to create custom Siri-like intelligent personal digital assistants for any connected device or service.

Last week, netTALK announced the Go Mobile campaign for iPhone and iPad. A user can link their netTALK DUO to the netTALK CONNECT Talk companion app to make and receive calls when they are in transit. It is currently available in the Apple App Store.

Anastasios "Takis" Kyriakides, netTALK Founder and Chief Executive Officer, said, "We believe everyone should have access to super simple and affordable home and on-the-go digital phone service. We connect you to our global communications network through our DUO devices and CONNECT mobile apps, which ring simultaneously - answer on the device that is most convenient to you. We provide a high tech, simple and ultra-low cost service with just one bill once a year."

Net Talk.com, Inc. (NTLK), closed Friday's trading session at $0.0128, down 2.29%, on 761,992 volume with 17 trades. The average volume for the last 60 days is 88,433 and the stock's 52-week low/high is $0.0129/$0.361.

NuGene International, Inc. (NUGN)

Today we are highlighting NuGene International, Inc. (NUGN), here at the QualityStocks Daily Newsletter.

Irvine, California-based NuGene International, Inc. specializes in developing, manufacturing, and marketing proprietary regenerative cosmeceutical and pharmaceutical products. These are based on adipose derived human stem cell and human stem cell media. The Company’s goal is to take advantage of its extensive knowledge and expertise to develop age defying regenerative cosmeceutical skincare and hair care products as well as pharmaceutical products based on the same regenerative science platform. NuGene BioPharma, Inc. is the Company’s subsidiary.

NuGene International’s cosmeceutical and pharmaceutical products are based on proprietary stem cell based regenerative formulations. These are derived from non-controversial, adult human stem cell derived media obtained from adipose tissue. The Company’s exclusive products combine its in-house advancements, proprietary technologies, as well as patent pending formulations.

NuGene has two patents pending encompassing 15 unique applications and inventions. The Company’s products include its Skin Care Collection and its Hair Care Collection. In November 2014, NuGene International entered into a License Agreement with kathy ireland Worldwide, Inc. NuGene licensed the right to use the trademarks and rights to the name, likeness and visual representations of Kathy Ireland in connection with its cosmeceutical line of products containing adult human adipose stem cell derived or containing biologically active or biologically derived ingredients.

This month, NuGene announced that it launched a new campaign for the NuGene kathy ireland® brand. The campaign includes a re-branded Internet presence and new videos featuring Ms. Ireland. The Company indicates that the campaign will trigger the launch of a larger multi-media campaign.

NuGene’s intention is to run full page ads for the NuGene kathy ireland® products in industry magazines. These include InStyle, Vogue, Vanity Fair, American Academy of Dermatology, and American Society of Plastic Surgeons. This is to support brand recognition and build traffic to NuGene’s growing network of physicians, spas aestheticians and other skin and hair care professionals.

Last week, NuGene International announced that its subsidiary corporation, NuGene BioPharma acquired all rights, title and interest in and to SkinGuardian®, a Food and Drug Administration (FDA)-approved (monographed) skin protectant, antiseptic, and moisturizing topical cream. It acquired all intellectual property (IP) held by SkinGuardian and its Founder and Owner, Chris O'Brien, relating to the SkinGuardian technology and applications.

NuGene International, Inc. (NUGN), closed Friday's trading session at $1.96, up 3.70%, on 214,740 volume with 52 trades. The average volume for the last 60 days is 20,043 and the stock's 52-week low/high is $0.0086/$5.00.


The QualityStocks
Company Corner


Inventergy Global, Inc. (INVT)

The QualityStocks Daily Newsletter would like to spotlight Inventergy Global, Inc. (INVT). Today, Inventergy Global, Inc. closed trading at $0.7001, up 4.49%, on 162,334 volume with 215 trades. The stock’s average daily volume over the past 60 days is 293,753, and its 52-week low/high is $0.3904/$10.56.

Inventergy Global, Inc. today announced that its CEO, Chairman and Founder, Joe Beyers will be presenting Tuesday, June 16th at the IPBC Global 2015, presented by Intellectual Asset Magazine (see http://www.ipbusinesscongress.com/2015). Mr. Beyers will be speaking about how to build and maintain a successful licensing-based company, including:

• Understanding the challenges of the licensing landscape
• Building a robust IP portfolio
• Providing insight on new IP related business models

Inventergy Global, Inc. (INVT) is an intellectual property (IP) licensing partner specializing in IP value creation. Led by industry veteran Joe Beyers, former head of global licensing for Hewlett-Packard, Inventergy identifies, acquires and licenses patented technologies to help market-leading technology companies monetize and achieve more value from their innovations.

With more than 100 years of combined experience and track record of handling more than $15 billion in IP and technology transactions, Inventergy’s team of professionals handle every aspect of the IP business, from valuation and branding through legal analysis, decision making and patent sales.

Inventergy partners with world-class, market-significant companies who may lack internal manpower, budget or other resources necessary to realize appropriate return-on-investment. Through collaborative, business-centered, and forward-thinking strategies, Inventergy is able to create portfolios with significant market potential and optimize the innovator’s overall return-on-investment.

The company has established a network of key industry relationships to complement its solid licensing model and growing portfolio of assets, which currently stands at more than 760 global patent assets. Inventergy pursues maturing telecommunications technologies already adopted in the marketplace and earning accretive value. Disclaimer

Inventergy Global, Inc. Company Blog

Inventergy Global, Inc. News:

Inventergy Announces CEO & Chairman Joe Beyers to Present at IPBC Global 2015, San Francisco

Inventergy Announces Operational Restructuring of Its Product Businesses Designed to Improve Margins, Cash Flow and Earnings Growth

Inventergy Launches Standardized Licensing Initiative for Mobile Device Manufacturers

IFAN Financial, Inc. (IFAN)

The QualityStocks Daily Newsletter would like to spotlight IFAN Financial, Inc. (IFAN). Today, IFAN Financial, Inc. closed trading at $0.29, off by 7.64%, on 85,842 volume with 32 trades. The stock’s average daily volume over the past 60 days is 577,742, and its 52-week low/high is $0.0114/$1.01.

IFAN Financial, Inc. (IFAN) and its wholly owned subsidiaries, iPIN Technologies and Mobicash America, are engaged in the design, development and distribution of software that enhances and enables mobile payments. The San Diego-based company has a growing portfolio of solutions, including the ability to use a debit card and corresponding PIN number while purchasing online via mobile phone, tablet, or computer and peer-to-peer cash transfers.

Keeping pace with the evolution of the information and communication (ICT) market, iPIN Technologies intends to provide a range of processing services for the industry’s future devices. The company is currently developing a new method of online selling through debit card payments and processing. iPIN technology attaches to any smartphone through the headphone jack and converts the device into a consumer PIN debit, same-as-cash payment solution. Using the iPIN Debit app, transactions are processed through the private and secure iPIN Technologies Network.

Mobicash America is an early-stage technology company that develops mobile payment solutions. The company’s platform product, Quidme, utilizes the text messaging function of a mobile phone, allowing the technology to operate on almost any phone or network, with or without data service. The functionality of the Quidme platform allows users to pay bills, purchase goods and services, and to send money to friends and relatives located locally or internationally via simple text message.

IFAN Financial continues to explore opportunities to expand its product portfolio to meet the growing demands for consumer/merchant convenience, speed and security within the mobile commerce market. Products in development will combine the functionality of social media, e-commerce and banking with the broader conveniences of the mobile environment. Disclaimer

IFAN Financial, Inc. Company Blog

IFAN Financial, Inc. News:

IFAN Financial Applauds Facebook's Move Into the Mobile Payments Industry, Foresees Ancillary Opportunities

IFAN Financial Begins Beta Testing With Nation's Largest Debit Card Acquiring Processor

IFAN Financial Reaches Technology Development Milestones

Sparta Commercial Services, Inc. (SRCO)

The QualityStocks Daily Newsletter would like to spotlight Sparta Commercial Services, Inc. (SRCO). Today, Sparta Commercial Services, Inc. closed trading at $0.075, up 22.95%, on 94,600 volume with 10 trades. The stock’s average daily volume over the past 60 days is 153,884, and its 52-week low/high is $0.0496/$1.25.

Sparta Commercial Services, Inc. (SRCO) is a New York-based technology company whose subsidiary, Specialty Reports, Inc., is a leader in developing, managing, and servicing custom mobile apps for small and medium sized businesses as well as for retail vehicle dealers, in addition to providing motor vehicle title history reports to dealers, insurance companies, financial institutions, consumers, and other interested parties. Sparta Commercial Services also offers and administers vehicle and capital equipment lease financing programs for municipalities.

iMobileApp.com develops and services customized mobile applications for powersports, automobile, recreation vehicle, marine, and agriculture equipment dealers as well as for racetracks, restaurants, liquor stores, schools and any other small to medium sized company. The iMobileApp allows businesses to stay in touch with their customers, to notify them of upcoming and ongoing promotions, special events, and provide them with the ability to view new and used inventory, communicate directly with the service department, and more. The mobile application is generated, packaged, and made available on-line, at no cost to the company's customers, through the Apple App Store and the Google Play Store.

The company also serves as a one-stop online source for various types of vehicle title history reports, including motorcycles, recreation vehicles, automobiles, light trucks, and commercial (heavy duty) trucks. Its online history report products include Cyclechex.com, a motorcycle vehicle title history report provider; RVchecks.com, a RV vehicle title history report provider; and CarVinReport.com, an automobile and light truck vehicle title history report provider, and TruckChex.com, a commercial (heavy duty) truck vehicle title history report provider.

In addition to consumers – both buyers and sellers – vehicle dealerships, insurance companies, financial institutions and others benefit from the information provided on these vehicle title history reports. The Specialty Reports, Inc. vehicle title history reports are featured online at NADAGuides.com, KBB.com and DMV.org, prominent online sources for pre-owned vehicle values and other important information for both buyers and sellers.

The company’s Municipal Lease Financing Program for local and/or state agencies throughout the country provides an economical way to finance essential equipment, from police motorcycles and cruisers to EMS equipment and busses, to virtually any type of equipment required. The lease purchase financing program receives considerable praise for its understanding of government acquisition procedures and its work with a wide range of vendors.

Sparta Commercial Services is an innovative and diversified company that has proven its ability to identify the needs and interests of its targeted markets, as well as develop products and services specifically designed to meet those needs and interests now and well into the future. With a full suite of offerings that address the challenges of the powersports, recreation, and auto industries, the company is well positioned to achieve strong future growth rates. Disclaimer

Sparta Commercial Services, Inc. Company Blog

Sparta Commercial Services, Inc. News:

iMobileApp's Customer Base Continues to Diversify

Sparta Commercial Reports Continued Sales Growth

iMobileApp's Customer Base Continues to Grow and Broaden

International Stem Cell Corp. (ISCO)

The QualityStocks Daily Newsletter would like to spotlight International Stem Cell Corp. (ISCO). Today, International Stem Cell Corp. closed trading at $0.061, up 6.09%, on 1,552,989 volume with 90 trades. The stock’s average daily volume over the past 60 days is 503,470, and its 52-week low/high is $0.0555/$0.22.

International Stem Cell Corp. (ISCO) specializes in the therapeutic applications of human stem cells and the development and commercialization of cell-based biomedical products. The company was the first to develop and perfect a new class of human stem cells called parthenogenetic stem cells, created from unfertilized human eggs. ISCO has a strong patent portfolio offering clean intellectual property and freedom to operate. The company’s stem cells present superior immune matching capabilities and can be used in millions of people regardless of sex or racial background, with minimal expectation of immune rejection after transplantation.

The company’s human stem cells have been shown to be as pluripotent as embryonic stem cells, however their creation does not involve the destruction of a viable human embryo, which effectively sidesteps the controversy and ethical dilemmas associated with the use of human embryonic stem cells. In contrast to induced pluripotent stem cells, ISCO’s stem cells do not involve manipulation of cells’ genome thereby avoiding potential safety and regulatory obstacles in clinical applications.

The company's scientists are currently focused on using its stem cells to treat severe unmet medical needs of the central nervous system (Parkinson’s disease), the liver and the eye, where cell therapy has been clinically proven but is limited due to the unavailability of safe human cells. Once the technology has been clinically validated there are an essentially unlimited number of potential applications. Because of their immune-matching ability a relatively small number of these stem cell lines could offer the potential of producing the first true stem cell bank as a means of serving populations of different immune types across the globe.

In addition to its therapeutic focus, ISCO also provides a growing revenue stream through two wholly owned subsidiaries. Lifeline Cell Technology specializes in producing primary human cells and growth media for biological research, and Lifeline Skin Care, the company manufactures and markets advanced anti-aging skincare products utilizing the company’s expertise in stem cell biology. Disclaimer

International Stem Cell Corp. Company Blog

International Stem Cell Corp. News:

International Stem Cell Corporation Receives Key Stem Cell Patent in Japan

International Stem Cell Corporation Announces Completion of Cell Bank for Parkinson's Disease Clinical Trial

International Stem Cell Corporation to Conduct Parkinson's Disease Clinical Study in Australia

Well Power Inc. (WPWR)

The QualityStocks Daily Newsletter would like to spotlight Well Power Inc. (WPWR). Today, Well Power Inc. closed trading at $0.00965, up 7.22%, on 446,862 volume with 26 trades. The stock’s average daily volume over the past 60 days is 221,834, and its 52-week low/high is $0.0088/$0.3495.

Well Power Inc. (WPWR) has secured the licensing rights to Texas with the first right of refusal on the other US states to a new technology solution to process waste natural gas, such as vented, flared or stranded gas, into “clean power” and engineered fuels, including no-sulphur diesel and diluents. Based on proprietary technology, this solution is mobile, high-yield and can be deployed with minimum capital expenditure.

The company plans to be able to provide its technology with full-service engineering, design, construction, modular fabrication, maintenance and construction management services to clients in the upstream areas of exploration and production. Well Power will also offer consulting services, process assessments, facility appraisals, feasibility studies, technology evaluations, project finance structuring and support, and multi-client subscription services.

Approximately 2.4 million barrels of oil equivalent is wasted each day by gas flaring alone, resulting in $10 billion of lost revenue and 400 million metric tons of CO2 equivalent global greenhouse gas emissions each year. Additionally, environmental degradation associated with gas flaring has been shown to have a significant impact on local populations, often resulting in loss of livelihood and severe health issues.

Well Power’s Micro Refinery Unit (MRU) offers the opportunity to create value from a wasted resource while simultaneously enabling wider access to energy, improved environmental conditions, and economic development for local populations. By eliminating legacy flaring and minimizing new flaring, the company is well positioned to take a leadership role in the ongoing push for sustainable resource development and energy efficiency. Disclaimer

Well Power Inc. Company Blog

Well Power Inc. News:

Well Power Inc. Appoints Professional Engineer, Oil & Gas Veteran to Board of Directors

Well Power - Letter from President to Shareholders

Well Power Inc. to host second webinar on proprietory micro-refinery technology

One World Holdings, Inc. (OWOO)

The QualityStocks Daily Newsletter would like to spotlight One World Holdings, Inc. (OWOO). Today, One World Holdings, Inc. closed trading at $0.0069, up 18.97%, on 9,747,379 volume with 150 trades. The stock’s average daily volume over the past 60 days is 4,320,889, and its 52-week low/high is $0.0008/$0.18.

One World Holdings, Inc. (OWOO) subsidiary, The One World Doll Project, was established in 2010 to make a significant positive cultural impact through the doll category, transcending global and ethnic borders to create positive self-image in young women and girl around the world. Led by worldwide famous doll designer Stacy McBride-Irby, The One World Doll Project team has more than 50 collective years in the doll and toy industry and is dedicated and armed with the experience to ensure that the dolls are of the highest quality and value.

In 2013, the company released its Prettie Girls!™ line of multi-cultural fashion dolls uniquely designed with individual physical attributes, personal stories and hobbies, and goals and inspirations. For young girls, the dolls are a friend, a partner in play, and a glimpse of their biggest, brightest dreams. For young women, the dolls are a symbol of who they are and what they can achieve. For doll connoisseurs, The One World Doll Project promises stylish works of art that will become a vital part of a growing collectors’ market.

The One World Doll Project also has a Signature Celebrity Collection of Prettie Girls! and in 2013 released its first celebrity collectors doll modeled after supermodel Cynthia Bailey from The Real Housewives of Atlanta. Since the release of the doll, it has been showcased with Synthia on The Arsenio Hall Show, What Happens Live with Andy Cohen and The Bethenny Show.

Using a web-based sales model, One World Holdings plans to quickly capture significant market share in the dolls and stuffed toys space. After securing a strong online presence, the company will focus on brick and mortar retailing as it moves toward the ultimate pursuit of expanding worldwide. The company has established distribution deals with Toys “R” Us, HEB, dollgenie.com, Tuckers Toy Shop, pattycakedoll.com, and has recently expanded its retail presence internationally with the People’s Pharmacy storechain in the Central American country of Belize. The Prettie Girls! Dolls have been featured in national and international media spotlights like CNN, The Wall Street Journal, Jet Magazine, Bloomberg.com, Parade.com, Dolls Magazine, The Toy Book, The Houston Chronicle and Houston Business Journal, and TheStreet.com. Disclaimer

One World Holdings, Inc. Company Blog

One World Holdings, Inc. News:

The One World Doll Project to Announce National Retail Store Roll Out of the Prettie Girls! Dolls On April 6 Conference Call

The One World Doll Project CEO Announces 2015 Revenue Projections in Stockholder Letter

The One World Doll Project and Doll Designer, Stacey Mcbride-Irby Featured in Huffington Post

Zenosense, Inc. (ZENO)

The QualityStocks Daily Newsletter would like to spotlight Zenosense, Inc. (ZENO). Today, Zenosense, Inc. closed trading at $0.20, even for the day, on 19,265 volume with 9 trades. The stock’s average daily volume over the past 60 days is 26,899, and its 52-week low/high is $0.13/$1.00.

Zenosense, Inc. (ZENO) is developing and intends to market a novel device to enable hospitals to detect Methicillin-resistant Staphylococcus Aureus (MRSA) bacterial contamination, a major constituent of Hospital Acquired Infections (HAIs). The annual costs of treating hospitalized MRSA patients are estimated to be between $3.2 billion and $4.2 billion in the United States alone. MRSA infected patients are likely to spend three times as long in a hospital stay at three times the cost, and are five times more likely to die than an uninfected patient.

Early detection of MRSA and HAIs in general is vital. Recent studies suggest that implementing prevention practices can lead to up to a 70 percent reduction in certain HAIs with a financial benefit of using these prevention practices estimated to be as high as $25.0 billion to $31.5 billion in medical cost savings in the United States alone (according to a report by the Centers for Disease Control and Prevention, part of the US Department of Health and Human Sciences). Currently, no cost effective early detection device is available.

The Zenosense MRSA detection device is expected to act like a “smoke detector” for MRSA; designed to detect MRSA in the environment or infected patient, even before a patient demonstrates any obvious symptoms, satisfying this huge unmet need.

Zenosense has an agreement with leading European sensor developer Sgenia Group, which is developing such a device exclusively for Zenosense through their subsidiary Zenon Biosystem. The estimated manufacturing cost per device is under $100 USD and possibly as low as $50 USD. The Zenosense device, utilizing established Sgenia programming and patent-pending hardware, utilizes a single sensor to perform an infinite number of scans, creating tens of thousands of "virtual sensors". The low cost and compact design of the Zenosense device, if successfully developed, would make it possible to be worn by individuals, as well as placed in numerous sensitive areas in the healthcare setting.

Zenosense has a streamlined management team experienced in high-level marketing in the medical sector, supported by the outsourced Zenon Biosystem scientific/development team of qualified personnel with extensive knowledge and experience in the development of sensors. Both of these teams will fuse together through a high level advisory board of experienced professionals. A cost-effective Zenosense MRSA detection device, once developed, is expected to be in high demand, driven by patient safety, cost and insurance considerations. Disclaimer

Zenosense, Inc. Company Blog

Zenosense, Inc. News:

Zenosense, Inc. - Hospital Collaboration - 400 Person Lung Cancer Detection Trial

Zenosense, Inc.; Stock Now DTC DWAC/FAST Eligible

Zenosense, Inc. Reports Manufacturing of Pre-Commercial Lung Cancer Detection Device


Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters





Wall Street Resources



By The Numbers Charts

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors


The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.


About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251